193 related articles for article (PubMed ID: 12362260)
41. Encephalocraniocutaneous lipomatosis accompanied by maxillary compound odontoma and juvenile angiofibroma: report of a case.
Andreadis DA; Rizos CB; Belazi M; Peneva M; Antoniades DZ
Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):889-91. PubMed ID: 15523665
[TBL] [Abstract][Full Text] [Related]
42. Encephalocraniocutaneous lipomatosis accompanied by the formation of bone cysts: Harboring clues to pathogenesis?
Moog U; Roelens F; Mortier GR; Sijstermans H; Kelly M; Cox GF; Robson CD; Kimonis VE
Am J Med Genet A; 2007 Dec; 143A(24):2973-80. PubMed ID: 18000896
[TBL] [Abstract][Full Text] [Related]
43. Presurgical evaluation and cognitive functional reorganization in Fishman syndrome.
Donaire A; Carreno M; Bargalló N; Setoaín X; Agudo R; Martín G; Boget T; Raspall T; Pintor L; Rumiá J
Epilepsy Behav; 2005 May; 6(3):440-3. PubMed ID: 15820357
[TBL] [Abstract][Full Text] [Related]
44. Lipomatosis encefalocraneocutánea: reporte de caso.
Muñoz-Montufar JP; Rayo-Mares JD; Reyes-Cuayahuitl A; Pacheco-Rosas DO; Rangel-Ramírez MP
Gac Med Mex; 2017; 153(7):915-918. PubMed ID: 29414957
[TBL] [Abstract][Full Text] [Related]
45. Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis.
Bennett JT; Tan TY; Alcantara D; Tétrault M; Timms AE; Jensen D; Collins S; Nowaczyk MJM; Lindhurst MJ; Christensen KM; Braddock SR; Brandling-Bennett H; Hennekam RCM; Chung B; Lehman A; Su J; Ng S; Amor DJ; ; ; Majewski J; Biesecker LG; Boycott KM; Dobyns WB; O'Driscoll M; Moog U; McDonell LM
Am J Hum Genet; 2016 Mar; 98(3):579-587. PubMed ID: 26942290
[TBL] [Abstract][Full Text] [Related]
46. [Encephalocraniocutaneous lipomatosis and didymosis aplasticopsilolipara].
Martí N; Alonso V; Jordá E
Actas Dermosifiliogr; 2012 May; 103(4):341-2. PubMed ID: 22192510
[No Abstract] [Full Text] [Related]
47. Encephalocraniocutaneous Lipomatosis: A Case With Long Term Follow-up.
Bauld H; McNeely PD
Can J Neurol Sci; 2014 Jan; 41(1):106-8. PubMed ID: 24384349
[No Abstract] [Full Text] [Related]
48. Encephalocraniocutaneous lipomatosis (Haberland's syndrome): a case report of a neurocutaneous syndrome and a review of the literature.
Koishi GN; Yoshida M; Alonso N; Matushita H; Goldenberg D
Clinics (Sao Paulo); 2008 Jun; 63(3):406-8. PubMed ID: 18568254
[No Abstract] [Full Text] [Related]
49. Encephalocraniocutaneous lipomatosis with Wilms' tumor.
Damar Ç; Yaman A; Ali İkidağ M; Pekpak E; Olgaç A
Pediatr Int; 2017 Jul; 59(7):835-836. PubMed ID: 28612492
[No Abstract] [Full Text] [Related]
50. Ophthalmologic abnormalities in encephalocraniocutaneous lipomatosis.
MacLaren MJ; Kluijt I; Koole FD
Doc Ophthalmol; 1995; 90(1):87-98. PubMed ID: 8549249
[TBL] [Abstract][Full Text] [Related]
51. Encephalocraniocutaneous lipomatosis: a new neurocutaneous syndrome.
Sanchez NP; Rhodes AR; Mandell F; Mihm MC
Br J Dermatol; 1981 Jan; 104(1):89-96. PubMed ID: 6893936
[TBL] [Abstract][Full Text] [Related]
52. Low-grade astrocytoma in a child with encephalocraniocutaneous lipomatosis.
Brassesco MS; Valera ET; Becker AP; Castro-Gamero AM; de Aboim Machado A; Santos AC; Scrideli CA; Oliveira RS; Machado HR; Tone LG
J Neurooncol; 2010 Feb; 96(3):437-41. PubMed ID: 19652916
[TBL] [Abstract][Full Text] [Related]
53. Encephalocraniocutaneous Lipomatosis (Haberl and syndrome): A case report and review of literature.
Koti K; Bhimireddy V; Dandamudi S; Gunnamreddy R
Indian J Dermatol; 2013 May; 58(3):232-4. PubMed ID: 23723477
[TBL] [Abstract][Full Text] [Related]
54. Encephalocraniocutaneous lipomatosis with otolaryngologic manifestations: a rare neurocutaneous syndrome.
Sant'Anna GD; Saffer M; Mauri M; Facco S; Raupp S
Int J Pediatr Otorhinolaryngol; 1999 Aug; 49(3):231-5. PubMed ID: 10519703
[TBL] [Abstract][Full Text] [Related]
55. Encephalocraniocutaneous Lipomatosis: A Rare Association With Tethered Spinal Cord Syndrome With Review of Literature.
Naous A; Shatila AR; Naja Z; Naja AS; Rajab M
Child Neurol Open; 2015; 2(1):2329048X14553297. PubMed ID: 28503585
[TBL] [Abstract][Full Text] [Related]
56. Navigating the complexities of encephalocraniocutaneous lipomatosis: a case series and review.
Pavanello M; Piro L; Roggero A; Rossi A; Cataldi M; Piatelli G
Childs Nerv Syst; 2024 Apr; 40(4):1251-1258. PubMed ID: 38217730
[TBL] [Abstract][Full Text] [Related]
57. Encephalocraniocutaneous lipomatosis: complete neuroradiologic evaluation and follow-up of two cases.
Parazzini C; Triulzi F; Russo G; Mastrangelo M; Scotti G
AJNR Am J Neuroradiol; 1999 Jan; 20(1):173-6. PubMed ID: 9974077
[TBL] [Abstract][Full Text] [Related]
58. Encephalocraniocutaneous lipomatosis: a new case report and review of the literature.
Romiti R; Rengifo JA; Arnone M; Sotto MN; Valente NY; Jansen T
J Dermatol; 1999 Dec; 26(12):808-12. PubMed ID: 10659502
[TBL] [Abstract][Full Text] [Related]
59. Cicatricial upper eyelid retraction in encephalocraniocutaneous lipomatosis: a report of two cases and review of literature.
Cruz AA; Schirmbeck T; Pina-Neto JM; Funayama CA
Ophthalmic Plast Reconstr Surg; 2002 Mar; 18(2):151-5. PubMed ID: 11897958
[TBL] [Abstract][Full Text] [Related]
60. Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis.
Boppudi S; Bögershausen N; Hove HB; Percin EF; Aslan D; Dvorsky R; Kayhan G; Li Y; Cursiefen C; Tantcheva-Poor I; Toft PB; Bartsch O; Lissewski C; Wieland I; Jakubiczka S; Wollnik B; Ahmadian MR; Heindl LM; Zenker M
Clin Genet; 2016 Oct; 90(4):334-42. PubMed ID: 26970110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
